Nipro Diagnostics Introduces Extensive New Line of Ancillary Products for the Diabetes Category

TRUEplus™ Line Provides Additional Diabetes Care Solutions with Exceptional Quality, Value and Affordability

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Nipro Diagnostics, Inc. – a leading manufacturer and marketer of blood glucose monitoring products and diabetes management supplies – today announced that it has begun to ship to major retailers and wholesale distributors a new portfolio of more than 30 ancillary products targeted to meet the needs of individuals with diabetes. The TRUEplus™ products are designed to offer innovative, affordable solutions for diabetes patients to lead healthier lives. This new line also extends brand recognition and category sales for retailers who carry Nipro Diagnostics’ TRUE meter portfolio that includes TRUEresult® and TRUE2go® blood glucose monitors, among others.

“Launching the TRUEplus™ products provides us the opportunity to create a diabetes destination strategy leveraging our category expertise for the diabetic patient and their needs.”

The TRUEplus™ line includes fast-acting glucose tablets, shots and gels; ketone strips; diabetic multivitamins; syringes, lancets and lancing devices. “Launching the TRUEplus™ products provides us the opportunity to create a diabetes destination strategy leveraging our category expertise for the diabetic patient and their needs.” said Nipro President and CEO Scott Verner. “This initiative enables expansion of the TRUE brand and extends its message of exceptional quality and value, while further enhancing our mission of making quality diabetes care solutions more affordable.”

By adding TRUEplus™ products to their existing TRUE-brand meters, retailers can streamline ordering by working with a respected single-source supplier, achieve significant new margin opportunities and category growth, and amplify awareness of the diabetes meters/ancillary products brand that is associated with their stores.

Each item in the TRUEplus™ line adds features and benefits consistent with Nipro Diagnostics’ focus on innovation. For example, TRUEplus™ fast-acting glucose products (tablets, shots, and gels) include 400 IU of Vitamin D and come in convenient travel sizes so they can be taken easily anytime, anywhere.

About Nipro Diagnostics, Inc.

Based in Fort Lauderdale, Nipro Diagnostics, Inc. is a leading developer, manufacturer and marketer of diabetes management products. The company offers a portfolio of high quality blood glucose monitoring systems and ancillary products available around the world. Nipro Diagnostics is the exclusive supplier of diabetes care solutions, co-branded under the TRUE name, for leading pharmacies including Walgreens, CVS, Rite Aid and Publix; as well as for distributors and mail service providers such as McKesson, Cardinal Health, AmerisourceBergen, Invacare Supply Group and Liberty Medical. For more information, please visit www.niprodiagnostics.com.